Konrad Jan Karczewski, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome, Human | 24 | 2024 | 4456 | 1.600 |
Why?
|
Genetic Variation | 21 | 2024 | 6611 | 1.160 |
Why?
|
Genomics | 11 | 2024 | 5928 | 1.140 |
Why?
|
Trout | 1 | 2023 | 20 | 0.910 |
Why?
|
Databases, Genetic | 10 | 2024 | 1758 | 0.890 |
Why?
|
Genes, Essential | 2 | 2020 | 185 | 0.790 |
Why?
|
Computational Biology | 7 | 2016 | 3562 | 0.760 |
Why?
|
Blood Platelet Disorders | 1 | 2020 | 60 | 0.690 |
Why?
|
Models, Genetic | 4 | 2023 | 3449 | 0.600 |
Why?
|
Genetics, Population | 7 | 2023 | 944 | 0.570 |
Why?
|
Gene Frequency | 10 | 2023 | 3626 | 0.530 |
Why?
|
Genome-Wide Association Study | 22 | 2023 | 12801 | 0.510 |
Why?
|
Pharmacogenetics | 4 | 2014 | 683 | 0.480 |
Why?
|
Disease | 4 | 2023 | 673 | 0.480 |
Why?
|
Molecular Sequence Annotation | 5 | 2020 | 527 | 0.470 |
Why?
|
Software | 6 | 2024 | 4479 | 0.470 |
Why?
|
DNA Copy Number Variations | 7 | 2023 | 2055 | 0.470 |
Why?
|
User-Computer Interface | 3 | 2016 | 1406 | 0.430 |
Why?
|
Biological Specimen Banks | 4 | 2024 | 789 | 0.360 |
Why?
|
Phenotype | 16 | 2024 | 16731 | 0.350 |
Why?
|
Haploinsufficiency | 3 | 2022 | 334 | 0.350 |
Why?
|
Polymorphism, Single Nucleotide | 24 | 2023 | 16053 | 0.340 |
Why?
|
DNA | 1 | 2023 | 7214 | 0.340 |
Why?
|
Transcription Factors | 5 | 2021 | 12174 | 0.330 |
Why?
|
High-Throughput Nucleotide Sequencing | 8 | 2024 | 3671 | 0.330 |
Why?
|
Gene Expression Regulation | 6 | 2017 | 11932 | 0.330 |
Why?
|
Systems Biology | 1 | 2013 | 482 | 0.330 |
Why?
|
5' Untranslated Regions | 2 | 2021 | 255 | 0.320 |
Why?
|
Metabolomics | 2 | 2018 | 1675 | 0.320 |
Why?
|
Homozygote | 4 | 2023 | 1780 | 0.310 |
Why?
|
Genotype | 12 | 2023 | 13048 | 0.310 |
Why?
|
Sequence Analysis, DNA | 7 | 2023 | 4785 | 0.310 |
Why?
|
Mutation | 12 | 2024 | 30266 | 0.300 |
Why?
|
Genetic Diseases, Inborn | 1 | 2013 | 606 | 0.300 |
Why?
|
NF-kappa B | 2 | 2013 | 2492 | 0.280 |
Why?
|
Consanguinity | 3 | 2020 | 460 | 0.270 |
Why?
|
Alleles | 8 | 2024 | 6901 | 0.250 |
Why?
|
Proteomics | 2 | 2018 | 3914 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 14 | 2024 | 18068 | 0.230 |
Why?
|
Haplotypes | 6 | 2021 | 2725 | 0.200 |
Why?
|
Otosclerosis | 1 | 2023 | 113 | 0.190 |
Why?
|
Open Reading Frames | 4 | 2020 | 818 | 0.190 |
Why?
|
Humans | 75 | 2024 | 768970 | 0.190 |
Why?
|
Selection, Genetic | 2 | 2023 | 878 | 0.190 |
Why?
|
DNA Mutational Analysis | 5 | 2020 | 4124 | 0.190 |
Why?
|
Inheritance Patterns | 1 | 2023 | 344 | 0.190 |
Why?
|
DNA, Mitochondrial | 2 | 2023 | 872 | 0.180 |
Why?
|
Access to Information | 1 | 2023 | 317 | 0.180 |
Why?
|
Quantitative Trait Loci | 4 | 2017 | 2133 | 0.170 |
Why?
|
RNA Splice Sites | 2 | 2018 | 213 | 0.170 |
Why?
|
Nucleotides | 2 | 2022 | 455 | 0.170 |
Why?
|
Proteins | 4 | 2020 | 6011 | 0.170 |
Why?
|
Organelles | 1 | 2021 | 265 | 0.160 |
Why?
|
Cerebral Arteries | 1 | 2021 | 489 | 0.160 |
Why?
|
Rare Diseases | 3 | 2020 | 631 | 0.150 |
Why?
|
Exons | 5 | 2023 | 2395 | 0.150 |
Why?
|
Quantitative Trait, Heritable | 1 | 2021 | 540 | 0.150 |
Why?
|
INDEL Mutation | 2 | 2023 | 267 | 0.150 |
Why?
|
Human Genome Project | 2 | 2024 | 202 | 0.140 |
Why?
|
Penetrance | 2 | 2017 | 386 | 0.140 |
Why?
|
Genetics, Medical | 1 | 2020 | 334 | 0.140 |
Why?
|
Heterozygote | 5 | 2023 | 2798 | 0.140 |
Why?
|
Jews | 1 | 2018 | 359 | 0.130 |
Why?
|
RNA Splicing | 2 | 2018 | 905 | 0.130 |
Why?
|
Alternative Splicing | 2 | 2018 | 1105 | 0.130 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 229 | 0.120 |
Why?
|
Developmental Disabilities | 2 | 2021 | 1520 | 0.120 |
Why?
|
Warfarin | 2 | 2014 | 1493 | 0.120 |
Why?
|
Prion Diseases | 1 | 2016 | 99 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2023 | 2885 | 0.120 |
Why?
|
Multifactorial Inheritance | 1 | 2023 | 1423 | 0.120 |
Why?
|
Nervous System Malformations | 1 | 2015 | 243 | 0.110 |
Why?
|
Saccharomyces | 1 | 2013 | 62 | 0.110 |
Why?
|
Sequence Analysis, RNA | 3 | 2017 | 2041 | 0.110 |
Why?
|
Genes | 1 | 2017 | 1824 | 0.110 |
Why?
|
Health | 1 | 2016 | 398 | 0.100 |
Why?
|
Organ Specificity | 1 | 2017 | 1970 | 0.100 |
Why?
|
Vesicular Transport Proteins | 1 | 2015 | 377 | 0.100 |
Why?
|
Genome, Fungal | 1 | 2013 | 203 | 0.100 |
Why?
|
Exosomes | 1 | 2017 | 429 | 0.100 |
Why?
|
Gene Expression Profiling | 5 | 2015 | 9549 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2020 | 12806 | 0.100 |
Why?
|
Systole | 1 | 2014 | 937 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2020 | 2748 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2011 | 859 | 0.090 |
Why?
|
Diastole | 1 | 2014 | 785 | 0.090 |
Why?
|
Protein Binding | 3 | 2013 | 9344 | 0.090 |
Why?
|
Gene Dosage | 3 | 2023 | 1222 | 0.090 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 701 | 0.090 |
Why?
|
Genes, Synthetic | 1 | 2011 | 88 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2012 | 792 | 0.090 |
Why?
|
Genetic Techniques | 1 | 2013 | 428 | 0.090 |
Why?
|
RNA, Untranslated | 1 | 2014 | 457 | 0.090 |
Why?
|
Lipoproteins, HDL | 1 | 2015 | 682 | 0.090 |
Why?
|
Genome | 1 | 2019 | 1754 | 0.090 |
Why?
|
Search Engine | 1 | 2012 | 142 | 0.090 |
Why?
|
Myelodysplastic Syndromes | 1 | 2020 | 1399 | 0.090 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1399 | 0.090 |
Why?
|
Triglycerides | 2 | 2017 | 2464 | 0.080 |
Why?
|
Mitochondria | 1 | 2023 | 3682 | 0.080 |
Why?
|
Waist Circumference | 1 | 2013 | 935 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2017 | 1515 | 0.080 |
Why?
|
Gene Deletion | 1 | 2017 | 2674 | 0.080 |
Why?
|
Finland | 2 | 2023 | 609 | 0.080 |
Why?
|
Neurogenesis | 1 | 2015 | 865 | 0.080 |
Why?
|
Transcription Factor RelA | 1 | 2010 | 253 | 0.080 |
Why?
|
Transcription, Genetic | 2 | 2020 | 7609 | 0.080 |
Why?
|
Thrombophilia | 1 | 2011 | 308 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2830 | 0.080 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 800 | 0.080 |
Why?
|
Schizophrenia | 3 | 2023 | 6987 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1141 | 0.080 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20245 | 0.070 |
Why?
|
Folic Acid | 1 | 2014 | 1338 | 0.070 |
Why?
|
Cohort Studies | 6 | 2021 | 41808 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2016 | 2592 | 0.070 |
Why?
|
Evolution, Molecular | 2 | 2013 | 1894 | 0.070 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1820 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2542 | 0.060 |
Why?
|
Pakistan | 2 | 2017 | 299 | 0.060 |
Why?
|
Cell Cycle | 1 | 2014 | 2937 | 0.060 |
Why?
|
RNA Polymerase II | 1 | 2010 | 549 | 0.060 |
Why?
|
Binding Sites | 2 | 2011 | 6023 | 0.060 |
Why?
|
Crohn Disease | 1 | 2018 | 2294 | 0.060 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1672 | 0.060 |
Why?
|
Algorithms | 5 | 2024 | 14201 | 0.060 |
Why?
|
Sample Size | 2 | 2020 | 848 | 0.060 |
Why?
|
Pedigree | 3 | 2021 | 4545 | 0.060 |
Why?
|
Genetic Testing | 2 | 2020 | 3591 | 0.060 |
Why?
|
Biological Evolution | 1 | 2011 | 1077 | 0.060 |
Why?
|
Drug Discovery | 1 | 2012 | 1068 | 0.060 |
Why?
|
Genetic Loci | 3 | 2023 | 2630 | 0.060 |
Why?
|
Gene Pool | 1 | 2024 | 36 | 0.060 |
Why?
|
Geography | 2 | 2018 | 654 | 0.060 |
Why?
|
CpG Islands | 2 | 2020 | 1210 | 0.060 |
Why?
|
Blood Cell Count | 1 | 2024 | 406 | 0.060 |
Why?
|
Learning | 1 | 2013 | 1760 | 0.060 |
Why?
|
Homeostasis | 1 | 2014 | 3347 | 0.050 |
Why?
|
Reference Standards | 2 | 2020 | 1014 | 0.050 |
Why?
|
Founder Effect | 1 | 2023 | 185 | 0.050 |
Why?
|
Female | 17 | 2024 | 397515 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8745 | 0.050 |
Why?
|
Retinal Dystrophies | 1 | 2023 | 65 | 0.050 |
Why?
|
Male | 16 | 2024 | 365203 | 0.050 |
Why?
|
Neoplasms | 3 | 2024 | 22389 | 0.050 |
Why?
|
Toll-Like Receptor 7 | 1 | 2022 | 169 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2013 | 3580 | 0.050 |
Why?
|
Signal Recognition Particle | 1 | 2020 | 45 | 0.050 |
Why?
|
G-Quadruplexes | 1 | 2023 | 144 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3811 | 0.040 |
Why?
|
Middle Cerebral Artery | 1 | 2021 | 273 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2023 | 625 | 0.040 |
Why?
|
Base Sequence | 3 | 2020 | 12430 | 0.040 |
Why?
|
RNA Helicases | 1 | 2020 | 144 | 0.040 |
Why?
|
Curriculum | 1 | 2013 | 3782 | 0.040 |
Why?
|
Lymphocytes | 2 | 2020 | 2614 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 501 | 0.040 |
Why?
|
Animals | 5 | 2023 | 169335 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2020 | 508 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4712 | 0.040 |
Why?
|
Anticoagulants | 1 | 2014 | 4850 | 0.040 |
Why?
|
Adult | 7 | 2024 | 223851 | 0.040 |
Why?
|
Biology | 1 | 2020 | 292 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 769 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20776 | 0.040 |
Why?
|
Blood Pressure | 1 | 2014 | 8544 | 0.040 |
Why?
|
Cell Line | 3 | 2020 | 15604 | 0.040 |
Why?
|
Gene Flow | 1 | 2018 | 79 | 0.040 |
Why?
|
Automation | 1 | 2020 | 589 | 0.040 |
Why?
|
Population Density | 1 | 2018 | 193 | 0.040 |
Why?
|
Neuregulins | 1 | 2017 | 36 | 0.040 |
Why?
|
Reference Values | 1 | 2024 | 4940 | 0.040 |
Why?
|
Collagen Type VI | 1 | 2017 | 26 | 0.040 |
Why?
|
Genes, X-Linked | 1 | 2017 | 129 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2021 | 572 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2893 | 0.030 |
Why?
|
Infertility, Female | 1 | 2023 | 764 | 0.030 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 903 | 0.030 |
Why?
|
Cataract | 1 | 2023 | 837 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 286 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2018 | 473 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2022 | 22296 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2016 | 224 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1608 | 0.030 |
Why?
|
Brain | 2 | 2020 | 27453 | 0.030 |
Why?
|
Apolipoprotein C-III | 1 | 2017 | 210 | 0.030 |
Why?
|
Chromosomes, Human, X | 1 | 2017 | 321 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2024 | 1887 | 0.030 |
Why?
|
Receptors, KIR | 1 | 2015 | 114 | 0.030 |
Why?
|
Social Class | 1 | 2024 | 2009 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2023 | 4625 | 0.030 |
Why?
|
Postprandial Period | 1 | 2017 | 320 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2020 | 1328 | 0.030 |
Why?
|
Middle Aged | 8 | 2024 | 223737 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15661 | 0.030 |
Why?
|
Prions | 1 | 2016 | 177 | 0.030 |
Why?
|
Parturition | 1 | 2018 | 456 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6569 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2017 | 705 | 0.030 |
Why?
|
Embryonic Stem Cells | 1 | 2020 | 1251 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 808 | 0.030 |
Why?
|
Muscular Diseases | 1 | 2017 | 553 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 520 | 0.030 |
Why?
|
Longevity | 1 | 2020 | 1077 | 0.030 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2013 | 246 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 2013 | 265 | 0.020 |
Why?
|
Cholesterol | 1 | 2021 | 2913 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2431 | 0.020 |
Why?
|
Base Composition | 1 | 2011 | 291 | 0.020 |
Why?
|
Child | 4 | 2024 | 80960 | 0.020 |
Why?
|
Artifacts | 1 | 2020 | 1942 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2012 | 474 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2020 | 1682 | 0.020 |
Why?
|
Fertility | 1 | 2016 | 771 | 0.020 |
Why?
|
Quality Control | 1 | 2014 | 836 | 0.020 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2012 | 168 | 0.020 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 1094 | 0.020 |
Why?
|
Fasting | 1 | 2017 | 1610 | 0.020 |
Why?
|
Congenital Abnormalities | 1 | 2015 | 704 | 0.020 |
Why?
|
Rhinovirus | 1 | 2012 | 209 | 0.020 |
Why?
|
Behavior | 1 | 2013 | 543 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2013 | 662 | 0.020 |
Why?
|
HLA Antigens | 1 | 2015 | 1336 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2010 | 224 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3345 | 0.020 |
Why?
|
DNA, Intergenic | 1 | 2010 | 108 | 0.020 |
Why?
|
Transcription Initiation Site | 1 | 2010 | 190 | 0.020 |
Why?
|
tau Proteins | 1 | 2020 | 2146 | 0.020 |
Why?
|
Dietary Fats | 1 | 2017 | 2002 | 0.020 |
Why?
|
Fungal Proteins | 1 | 2013 | 907 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3450 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1505 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4528 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2013 | 2000 | 0.020 |
Why?
|
Aged | 4 | 2024 | 171786 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2452 | 0.020 |
Why?
|
Mendelian Randomization Analysis | 1 | 2014 | 1040 | 0.020 |
Why?
|
Autistic Disorder | 1 | 2017 | 1240 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2017 | 3433 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2179 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2011 | 1498 | 0.020 |
Why?
|
Europe | 1 | 2014 | 3441 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1891 | 0.020 |
Why?
|
Risk Factors | 3 | 2023 | 74976 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5891 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1673 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1891 | 0.020 |
Why?
|
Parkinson Disease | 1 | 2020 | 2895 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5505 | 0.020 |
Why?
|
Bipolar Disorder | 1 | 2023 | 5131 | 0.020 |
Why?
|
Species Specificity | 1 | 2010 | 2417 | 0.020 |
Why?
|
United States | 1 | 2013 | 73186 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4879 | 0.020 |
Why?
|
Mothers | 1 | 2016 | 2209 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2017 | 2057 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2015 | 2986 | 0.010 |
Why?
|
Adiposity | 1 | 2013 | 1895 | 0.010 |
Why?
|
Family | 1 | 2014 | 3208 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4428 | 0.010 |
Why?
|
Coronary Disease | 1 | 2017 | 5919 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2013 | 3139 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59739 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15879 | 0.010 |
Why?
|
Risk Assessment | 2 | 2014 | 24333 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10765 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3112 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2012 | 2171 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4056 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5804 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 40261 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11521 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 13055 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 81903 | 0.010 |
Why?
|
Mice | 1 | 2023 | 82072 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9618 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 30046 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12253 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 60131 | 0.000 |
Why?
|